Enterome
FranceEntry
2024
Hold
2yr
Status
Active
Who owns Enterome?
Enterome is a French Biotech company, currently owned by Primo Capital SGR since 2024 and 3 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
Primo Capital SGRPrimo Climate · 2024 · VC
4 ownership periods · full history below
Key facts
Key takeaways
- ·Co-held by Lundbeckfonden BioCapital, Seventure Partners, Principia SGR and Primo Capital SGR since 2012.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-held by Lundbeckfonden BioCapital, Seventure Partners, Principia SGR and Primo Capital SGR since 2012.
Co-invest · 4 holders · 2012 · present
Seventure PartnersActive
2016 · present(10yr) · Health for Life Capital · 2014 · VC
Principia SGRActive
2018 · present(8yr) · Principia III - Health · 2014 · Life Sciences VC
Primo Capital SGRActive
2024 · present(2yr) · Primo Climate · 2024 · VC
More from Primo Climate
Other portfolio companies in the same fund.
Italy
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Enterome?
Enterome is currently owned by Primo Capital SGR, Principia SGR and 2 others, through Primo Climate, since 2024.
When did Primo Capital SGR and 3 others acquire Enterome?
Primo Capital SGR and 3 others acquired Enterome in 2024.
Who has owned Enterome over time?
Enterome has been through 4 private-equity ownership periods: Lundbeckfonden BioCapital · via Lundbeckfonden BioCapital · since 2012; Seventure Partners · via Health for Life Capital · since 2016; Principia SGR · via Principia III - Health · since 2018; Primo Capital SGR · via Primo Climate · since 2024.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue